149 related articles for article (PubMed ID: 4105711)
1. Serum-lipids in women on oral contraceptives.
Stokes T; Wynn V
Lancet; 1971 Sep; 2(7726):677-80. PubMed ID: 4105711
[No Abstract] [Full Text] [Related]
2. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
3. Massive hyperlipemia during estrogen therapy.
Molitch ME; Oill P; Odell WD
JAMA; 1974 Feb; 227(5):522-5. PubMed ID: 4358883
[No Abstract] [Full Text] [Related]
4. Oral contraceptives and thromboembolism.
Med Lett Drugs Ther; 1972 Aug; 14(17):61-2. PubMed ID: 4567564
[No Abstract] [Full Text] [Related]
5. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
6. Fasting serum lipids and serum lipoprotein distribution during oral contraceptive therapy in Nigerians.
Kuku SB; Akinyanju PA
J Obstet Gynaecol Br Commonw; 1973 Aug; 80(8):750-3. PubMed ID: 4725954
[No Abstract] [Full Text] [Related]
7. Oral contraceptives and serum lipids.
Barton GM; Freeman PR; Lawson JP
J Obstet Gynaecol Br Commonw; 1970 Jun; 77(6):551-4. PubMed ID: 5420748
[No Abstract] [Full Text] [Related]
8. Effect of selected estrogens and progestins on human chromosomes in vitro.
Stenchever MA; Jarvis JA; Kreger NK
Obstet Gynecol; 1969 Aug; 34(2):249-51. PubMed ID: 4183817
[No Abstract] [Full Text] [Related]
9. [Changes in plasma lipids caused by oral contraceptives].
Kaffarnik H
Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
[No Abstract] [Full Text] [Related]
10. Complications of oral contraceptive agents--a symposim. Contraceptives and lipid metabolism.
Fiser RH
West J Med; 1975 Jan; 122(1):35-8. PubMed ID: 162816
[No Abstract] [Full Text] [Related]
11. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs.
Inman WH; Vessey MP; Westerholm B; Engelund A
Br Med J; 1970 Apr; 2(5703):203-9. PubMed ID: 5443406
[TBL] [Abstract][Full Text] [Related]
12. [4 cases of hyperplastic gingivitis during estroprogestational contraception].
Muller M; Aloi JC; Namur E
Bull Fed Soc Gynecol Obstet Lang Fr; 1969; 21(3):329-31. PubMed ID: 5400375
[No Abstract] [Full Text] [Related]
13. [Evaluation of the hormonal constitution variants in regard to the prescription of oral contraceptives].
Krause J; Stamm H
Bibl Gynaecol; 1970; 55():57-73. PubMed ID: 4109992
[No Abstract] [Full Text] [Related]
14. Plasma protein changes induced by sequential type of contraceptive steroid pills.
Laurell CB; Kullander S; Thorell J
Clin Chim Acta; 1969 Aug; 25(2):294-6. PubMed ID: 5816601
[No Abstract] [Full Text] [Related]
15. Combined oral contraceptives. A statement by the committee on safety of drugs.
Br Med J; 1970 Apr; 2(5703):231-2. PubMed ID: 5443411
[No Abstract] [Full Text] [Related]
16. Oral contraceptive estrogen and plasma lipid levels.
Hedlin A; Kuksis A; Geher K
Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
[TBL] [Abstract][Full Text] [Related]
17. Effects of steroids on serum lipids and serum cholesterol binding reserve.
Roth MS; Donato DM; Lansman HH; Robertson EG; Hsia SL; LeMaire WJ
Am J Obstet Gynecol; 1978 Sep; 132(2):151-6. PubMed ID: 686104
[TBL] [Abstract][Full Text] [Related]
18. [Liver cell tumor induction by oral contraceptives].
Gräf KJ; Meyer zum Büschenfelde KH
Dtsch Med Wochenschr; 1980 Jan; 105(2):61-5. PubMed ID: 6766098
[No Abstract] [Full Text] [Related]
19. [Peroral contraceptives and thromboembolism].
Asperger Z
Lijec Vjesn; 1969 Jul; 91(7):779-82. PubMed ID: 4910828
[No Abstract] [Full Text] [Related]
20. Serum lipids during oral contraceptive exposure.
Corredor DG; Mendelsohn LV; Sabeh G; Sunder JH; Danowski TS
Clin Pharmacol Ther; 1970; 11(2):188-93. PubMed ID: 5416850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
